08:52 AM EDT, 07/01/2024 (MT Newswires) -- Health care stocks were flat to higher premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was inactive and the iShares Biotechnology ETF (IBB) was up 0.4% recently.

SpringWorks Therapeutics ( SWTX ) advanced by nearly 4% after saying it has submitted a new-drug application to the US Food and Drug Administration for mirdametinib to treat patients with neurofibromatosis type 1- associated plexiform neurofibromas, a rare genetic disorder.